Central Venous Catheters Market Report 2024

The central venous catheters market size has grown strongly in recent years. It will grow from $3.61 billion in 2023 to $3.94 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth observed during the historic period can be attributed to several factors, an increase in chronic diseases, advancements in infection control practices, heightened demand for intravenous therapy, greater use in medical emergencies, and a rise in trauma care applications.

The central venous catheters market size is expected to see strong growth in the next few years. It will grow to $5.62 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The anticipated growth during the forecast period can be attributed to several factors, a rising incidence of chronic diseases, growing demand for minimally invasive procedures, increased focus on infection prevention, expansion of healthcare infrastructure, and a higher number of cardiovascular patients. Key trends expected to shape the forecast period include the adoption of antimicrobial-coated catheters, technological advancements, developments in bioresorbable materials, the introduction of power-injectable CVCs, and improvements in catheter tip designs.

The anticipated growth in the central venous catheter market is largely driven by the increasing prevalence of kidney diseases. The rise in kidney disease cases is linked to a surge in chronic conditions such as diabetes and hypertension, which necessitate interventions such as central venous catheters for essential treatments, including dialysis. These catheters play a crucial role in managing kidney diseases by facilitating access to hemodialysis, medication administration, nutritional support, and frequent blood draws. For example, in June 2023, Kidney Research UK reported that kidney disease affects approximately 7.19 million people in the UK, or more than 10% of the population, with projections suggesting this number will rise to 7.61 million by 2033. Additionally, the proportion of patients in advanced stages of the disease is expected to increase from 45% to 51%, which will drive the demand for central venous catheters.

Key players in the central venous catheter market are focusing on developing advanced ultrasound systems to enhance the precision and safety of catheter insertion procedures. These systems improve catheter placement by offering real-time visualization, which boosts accuracy, reduces complications, and enhances patient comfort and procedural efficiency. For instance, in November 2023, Becton, Dickinson, and Company (BD), a US-based medical technology firm, introduced SiteRite 9, a sophisticated vascular access ultrasound system designed to increase clinician efficiency for placing peripherally inserted central catheters (PICCs), central venous catheters, IV lines, and other vascular access devices. The SiteRite 9 features a 15.6-inch touchscreen with superior image quality, the Cue needle tracking system for real-time needle tracking, and the Sherlock 3CG+ tip confirmation system for precise catheter navigation. BD's technology aims to streamline vascular access procedures with intelligent features such as vessel assessment and automated data capture.

In September 2022, B. Braun, a Germany-based medical technology company, acquired Clik-FIX catheter securement devices from Starboard Medical. This acquisition, the terms of which were not disclosed, aims to enhance B. Braun's central venous catheter market offerings by integrating advanced securement solutions to improve patient care and procedural efficiency. Starboard Medical Inc., based in the US, is a manufacturer of central venous catheters.

Major companies operating in the central venous catheters market are Medtronic plc, Becton, Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Terumo Corporation, Edwards Lifesciences Corporation, Teleflex Incorporated, Cook Group Incorporated, ICU Medical Inc., Lepu Medical Technology (Beijing) Co. Ltd, Merit Medical Systems Inc, Vygon SAS, AngioDynamics Inc., Argon Medical Devices Inc., Poly Medicure Limited, Vogt Medical Vertrieb GmbH, MedCath Corporation, GaltNeedleTech Inc., Romsons International, Newtech Medical Devices Private Limited, NIPRO Medical Corporation, DemeTECH Corporation, Scitech Medical Products SA, Prodimed, P. K. Scientific & Chemicals.

North America was the largest region in the central venous catheters market in 2023. The regions covered in the central venous catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the central venous catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Central venous catheters (CVCs) are medical devices designed for insertion into large veins to facilitate long-term intravenous therapy, medication administration, and blood draws. They enable quick delivery of treatment, minimize the need for repeated needle sticks, and support critical patient monitoring, making them crucial for complex medical care.

The central venous catheter market includes various types such as single-lumen, double-lumen, triple-lumen, and others. Single-lumen CVCs have one channel for delivering medications, fluids, or nutrients directly into the bloodstream. These catheters come with different properties, including antimicrobial-coated and non-antimicrobial-coated versions, and are used in various veins such as the jugular, subclavian, femoral, and others. The primary end users of CVCs are hospitals, ambulatory surgical centers, and other healthcare facilities.

The central venous catheters market research report is one of a series of new reports that provides central venous catheters market statistics, including the central venous catheters industry global market size, regional shares, competitors with central venous catheters market share, detailed central venous catheters market segments, market trends, and opportunities, and any further data you may need to thrive in the central venous catheters industry. These central venous catheters market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The central venous catheters market consists of sales of standard CVCs, peripherally inserted central catheters (PICCs), implantable ports, and specialty CVCs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.